Clinical Study
Clinical Significance of Optic Disc Progression by Topographic Change Analysis Maps in Glaucoma: An 8-Year Follow-Up Study
Table 4
Median times to clinical (ONH stereophotograph and/or Visual Field) progression for TCA-stable and TCA-progressed eyes throughout the whole followup.
| | Time (months) | Median (IQR) | | TCA-stable eyes
() | | TCA-progressed eyes
() | value |
| | Baseline to ONH SPG and/or VF progression | 5 | 7.42 (6.88, 7.73) | 11 | 7.94 (5.12, 8.52) | 0.20 | | Baseline to ONH SPG progression | 4 | 7.15 (6.84, 7.56) | 9 | 7.94 (5.24, 8.74) | 0.20 | | Baseline to VF progression | 1 | 7.73 (7.73, 7.73) | 5 | 5.01 (4.76, 8.07) | 0.20 |
| | Enrollment to ONH SPG and/or VF progression | 5 | 3.90 (3.36, 4.11) | 11 | 2.31 (1.85, 3.51) | 0.04 | | Enrollment to ONH SPG progression | 4 | 3.63 (3.35, 3.95) | 9 | 2.81 (1.96, 4.01) | 0.20 | | Enrollment to VF progression | 1 | 5.69 (5.69, 5.69) | 5 | 1.85 (1.75, 2.18) | 0.005 |
|
|
ONH: optic nerve head; TCA: topography change analysis; SPG: stereophotograph; VF: visual field; IQR: interquartile ranges; dots (.) denote nonestimable quantities.
|
